HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LASSBio-581

structure in first source

Also Known As:

1-(1-(4-chlorophenyl)-1H-(1,2,3)triazol-4-ylmethyl)-4-phenylpiperazine

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - LASSBio-581: 2

Experts

1.	Barreiro, Eliezer J: 2 articles (05/2010 - 03/2008)
2.	Fraga, Carlos A M: 2 articles (05/2010 - 03/2008)
3.	Neves, Gilda: 2 articles (05/2010 - 03/2008)
4.	Rates, Stela M K: 2 articles (05/2010 - 03/2008)
5.	Andrade, Carolina H: 1 article (05/2010)
6.	Menegatti, Ricardo: 1 article (05/2010)
7.	Noël, François: 1 article (05/2010)
8.	Pazini, Francine: 1 article (05/2010)
9.	Sabino, José R: 1 article (05/2010)
10.	de Oliveira, Valéria: 1 article (05/2010)

Related Diseases

1.

Schizophrenia (Dementia Praecox)

05/01/2010 - "LASSBio-581 is a N-phenylpiperazine derivative designed for the treatment of schizophrenia. "
03/01/2008 - "Previous studies have demonstrated that LASSBio-579 and LASSBio-581, two N-phenylpiperazine derivatives designed for the treatment of schizophrenia, are presynaptic dopamine D(2) receptor agonists that induce a hypothermic effect in mice that is not mediated by dopamine receptor activation. "

Related Drugs and Biologics

1.	phenylpiperazine
2.	Dopamine Receptors (Dopamine Receptor)
3.	Dopamine (Intropin)
4.	LASSBio-579